A Study of Botulinum Toxin Type A Treatment of Wrinkles in Asian
Status:
Completed
Trial end date:
2017-03-02
Target enrollment:
Participant gender:
Summary
OBJECTIVES： The aim of this randomized, parallel-group, double-blinded controlled multicenter
clinical trial is to determine the proper dosage of botulinum toxin type A in Asian, and
provide evidence-based proof.
METHODS: 250 patients were included in this study, first, trained observers assessed their
wrinkle severity according to the 5-grade Wrinkle Severity Rating Scale before injecting
botulinum toxin type A, then we injected different dosages to patients with the different
pre-injection scores. All patients were followed up for up to one year. Logistic regression
was built, the chi-square test was performed, and R square and p-value are used for
evaluation.
Phase:
Early Phase 1
Details
Lead Sponsor:
Shanghai Jiao Tong University School of Medicine
Treatments:
abobotulinumtoxinA Botulinum Toxins Botulinum Toxins, Type A